Mazdutide · perder grasa

Mazdutide

MDT

$149.00USD

Seleccione variante

Comprar por WhatsAppMejor precio

5mg x 10 vials

$149.00

Cold-chain shipping

COA per batch

Descripción

Mazdutide (also known as IBI362) is a once-weekly injectable dual agonist of the GLP-1 receptor and glucagon receptor (GCG), developed by Innovent Biologics in collaboration with Eli Lilly. It mimics the action of oxyntomodulin to suppress appetite, delay gastric emptying, increase energy expenditure, and promote fat breakdown. Clinical trials have shown strong weight loss (up to 15-20% at higher doses), improved blood glucose control, and cardiometabolic benefits, with mainly mild-to-moderate gastrointestinal side effects. It was approved in China in 2025 for chronic weight management in adults with overweight or obesity. This content is for research purposes only and is provided solely for reference. It must not be interpreted as health, clinical, or legal advice or guidance.

Más vendidos

Bac.water · Auxiliary Supplies

Bacteriostatic Water (often called Bac Water) is sterile water that contains 0.9% benzyl alcohol as a preservative. It is designed to inhibit the growth of bacteria, allowing multiple uses from a sing

Retatrutide · perder grasa

Retatrutide (LY3437943) is a first-in-class triple agonist peptide that simultaneously activates GLP-1, GIP, and glucagon receptors. This innovative triple mechanism delivers superior weight loss, inc

GHK-Cu · Arreglar

GHK-Cu (Copper Tripeptide-1) is a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) first identified in human plasma by Dr. Loren Pickart in 1973. Its levels decline significa

MOTS-c (Human) · perder grasa

MOTS-c is a 16-amino acid mitochondrial-derived peptide encoded in the 12S rRNA gene of mitochondrial DNA. Discovered in 2015 by Dr. Changhan David Lee at USC, it acts as an exercise mimetic by activa

Productos relacionados

Retatrutide · perder grasa

Retatrutide (LY3437943) is a first-in-class triple agonist peptide that simultaneously activates GLP-1, GIP, and glucagon receptors. This innovative triple mechanism delivers superior weight loss, inc

MOTS-c (Human) · perder grasa

MOTS-c is a 16-amino acid mitochondrial-derived peptide encoded in the 12S rRNA gene of mitochondrial DNA. Discovered in 2015 by Dr. Changhan David Lee at USC, it acts as an exercise mimetic by activa

Tirzepatide · perder grasa

Tirzepatide is a first-in-class dual GIP/GLP-1 receptor agonist that simultaneously activates both incretin pathways for synergistic metabolic effects. By combining GIP-mediated fat oxidation and lipi

Tesamorelin · perder grasa

Tesamorelin is a synthetic 44-amino acid analog of growth hormone-releasing hormone (GHRH) that is FDA-approved (as Egrifta®) for the reduction of excess visceral abdominal fat in adults with HIV-asso